NVAX

NVAX Operating Expenses

$549.49MTTM · USD

Period ending:

NVAX FY Operating ExpensesUSD
NVAX FY Operating Expenses1996-12-31: $5.90M1997-12-31: $5.60M1998-12-31: $6.20M1999-12-31: $6.20M2000-12-31: $15.81M2001-12-31: $29.27M2002-12-31: $33.00M2003-12-31: $25.78M2004-12-31: $29.23M2005-12-31: $10.77M2006-12-31: $22.82M2007-12-31: $31.56M2008-12-31: $35.42M2009-12-31: $37.71M2010-12-31: $38.84M2011-12-31: $29.26M2012-12-31: $37.05M2013-12-31: $65.13M2014-12-31: $99.36M2015-12-31: $193.49M2016-12-31: $284.47M2017-12-31: $202.89M2018-12-31: $208.21M2019-12-31: $148.26M2020-12-31: $439.11M2021-12-31: $1.88B2022-12-31: $1.34B2023-12-31: $779.13M2024-12-31: $728.35M2025-12-31: $489.07M$1.88B$0.00
1996-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

NVAX operating expenses history

Expenses from normal business operations (SG&A, R&D, etc.). The available annual fiscal periods series contains 30 observations from Dec 31, 1996 to Dec 31, 2025.

Novavax Inc Operating Expenses — Annual fiscal periods (USD)
Period endingOperating Expenses (USD)
489,068,000
728,354,000
779,125,000
1,341,048,000
1,884,157,000
439,107,000
148,259,000
208,206,000
202,886,000
284,466,000
193,486,000
99,363,000
65,127,000
37,049,000
29,264,000
38,837,000
37,708,000
35,424,000
31,563,000
22,817,000
10,768,000
29,234,000
25,782,000
33,004,000
29,269,000
15,811,000
6,200,000
6,200,000
5,600,000
5,900,000

Compare operating expenses

All NVAX financial metrics · NVAX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.